96 related articles for article (PubMed ID: 1855177)
1. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up.
Tullgren O; Grimfors G; Holm G; Johansson B; Svedmyr E; Wedelin C; Mellstedt H; Merk K; Björkholm M
Cancer; 1991 Aug; 68(4):768-75. PubMed ID: 1855177
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
Wedelin C; Björkholm M; Holm G; Ogenstad S; Johansson B; Mellstedt H
Br J Cancer; 1982 Jan; 45(1):70-9. PubMed ID: 6977367
[TBL] [Abstract][Full Text] [Related]
3. Increased serum CD8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of a poor prognosis in adult Hodgkin's disease.
Grimfors G; Andersson B; Tullgren O; Giscombe R; Holm G; Johansson B; Björkholm M
Br J Haematol; 1992 Feb; 80(2):166-71. PubMed ID: 1550771
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
Ayoub JP; Palmer JL; Huh Y; Cabanillas F; Younes A
Leuk Lymphoma; 1999 Aug; 34(5-6):519-27. PubMed ID: 10492075
[TBL] [Abstract][Full Text] [Related]
6. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
7. Immunologic profile of patients with cured Hodgkin's disease.
Bjorkholm M; Holm G; Mellstedt H
Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.
Axdorph U; Porwit-MacDonald A; Sjöberg J; Grimfors G; Ekman M; Wang W; Biberfeld P; Björkholm M
Br J Cancer; 1999 Dec; 81(7):1182-7. PubMed ID: 10584880
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
[TBL] [Abstract][Full Text] [Related]
10. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
Gocheva L; Koleva I
Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
[TBL] [Abstract][Full Text] [Related]
12. The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin's disease: the prognostic significance and the relationship to the presence of systemic symptoms.
MacLennan KA; Hudson BV; Jelliffe AM; Haybittle JL; Hudson GV
Clin Oncol; 1981 Dec; 7(4):333-9. PubMed ID: 7318276
[No Abstract] [Full Text] [Related]
13. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease.
Axdorph U; Porwit-MacDonald A; Grimfors G; Björkholm M
Leuk Lymphoma; 2001; 42(5):1055-65. PubMed ID: 11697623
[TBL] [Abstract][Full Text] [Related]
14. Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.
Wirth A; Chao M; Corry J; Laidlaw C; Yuen K; Ryan G; Byram D; Davis S; Kiffer J; Quong G; Liew K
J Clin Oncol; 1999 Jan; 17(1):230-40. PubMed ID: 10458238
[TBL] [Abstract][Full Text] [Related]
15. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.
Hasenclever D; Diehl V
N Engl J Med; 1998 Nov; 339(21):1506-14. PubMed ID: 9819449
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency and prognosis in patients with non-Hodgkin's lymphomas.
Lindemalm C; Biberfeld P; Björkholm M; Holm G; Johansson B; Mellstedt H; Nilsson B; Ost A
Acta Radiol Oncol; 1985; 24(2):159-65. PubMed ID: 2988279
[TBL] [Abstract][Full Text] [Related]
18. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
[TBL] [Abstract][Full Text] [Related]
19. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
20. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
